Element VITARI™
Scale without the premium.
- Scale output with up to 10 billion reads or 3 TB of data per dual-sided run
- Lower costs at scale
- Rely on high-confidence data with >90% Q30 data quality
- Flexible, right-sized run configurations using 2 independent flow cells with 6 lanes each
- Bring throughput into any lab, with a compact benchtop footprint
- Simplify logistics with ambient shipping of sequencing reagent cartridges
- Run times aligned with real lab workflows, ~36 hours (2 x 150)
- Compatible with VITARI™ Cloudbreak Freestyle™ and Trinity™ 2×150 and 2×75 kits
Shipping in H2 2026. Pre-order yours today.

VITARI. Scale without the premium!
Click on the questions to get the answers
Element Biosciences, founded in California in 2017 by a team of former Illumina executives, entered the market in 2022. In just five years, the company went from concept to commercial instrument, raising more than $400 million in funding along the way.
Over the past two years, Element Biosciences has experienced exponential growth, driving a true transformation in the sequencing industry, both from a technical and scientific perspective and in terms of cost and accessibility.
High-throughput sequencing has been built on compromise. Scale or flexibility. Performance or usability. Efficiency or quality.
VITARI changes that. Scale and flexibility coexist. Performance is intuitive. Quality is uncompromised. It’s built for what comes next.
